Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Parents breathe sigh of relief after windpipe surgery success
. It was big news this week when doctors at Children’s Hospital of Illinois performed the first successful pediatric transplant in the U.S. of a regenerated trachea using a synthetic scaffold. The Canadian father and Korean mother of two-year-old Hannah Genevieve Warren are delighted that their daughter, born without a windpipe, now has one grown […]
Right Turn: Primer on MSCs in clinical trials
. In this podcast titled “Opportunities and Challenges in Developing Innovative Stem Cell Therapies,” Dr. Armand Keating focuses specifically on the commercialization of mesenchymal stem cells (stromal cells). He has established the largest stem cell transplant program in Canada and his clinical and research interests focus on anti-cancer cell therapy, blood and marrow transplantation, leukemia, […]
Right Turn: Research at the bleeding edge. Literally.
How many university students can say they invented a product that people around the world will want to use? For that matter, how many people have ever invented a product that made it to the market?! Joe Landolina is CEO and Co-Founder of Suneris, Inc. and a student at the Polytechnic Institute of New York […]
Master debaters have bone (marrow) to pick at StemCellTalks Toronto
I’ve always had an interest in the science of bone marrow transplants, ever since my nephew, Simon, was diagnosed with aplastic anemia at the age of two. Although it was a traumatic time for his parents and extended family, the story has a happy ending. His four-year-old brother was a bone marrow match and the […]
Right Turn: our new Friday feature
Signals Blog has given itself the green light to try something different. We’re launching a brand new feature, to appear on Fridays, which will showcase the “lighter” side of regenerative medicine. We will be bringing you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you […]
Comments